Compare · LFST vs TOI
LFST vs TOI
Side-by-side comparison of LifeStance Health Group Inc. (LFST) and The Oncology Institute Inc. (TOI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LFST and TOI operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- LFST is the larger of the two at $2.87B, about 5.9x TOI ($486.9M).
- Over the past year, LFST is up 25.6% and TOI is up 87.5% - TOI leads by 61.8 points.
- TOI has been more active in the news (8 items in the past 4 weeks vs 2 for LFST).
- LFST has more recent analyst coverage (17 ratings vs 7 for TOI).
- Company
- LifeStance Health Group Inc.
- The Oncology Institute Inc.
- Price
- $7.40-3.14%
- $4.87+2.75%
- Market cap
- $2.87B
- $486.9M
- 1M return
- +0.27%
- +28.36%
- 1Y return
- +25.64%
- +87.48%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2020
- News (4w)
- 2
- 8
- Recent ratings
- 17
- 7
LifeStance Health Group Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.
The Oncology Institute Inc.
The Oncology Institute, Inc. provides cancer awareness, prevention, diagnosis, treatment, and education service. The company offers chemotherapy education, comprehensive lab testing, pain management, financial counseling, end of life counseling, dietary counseling, in-house infusion center, in-house support groups, in-house pharmacy, nutraceuticals, clinical trials, and educational seminars. It also operates the hope, health, and healing center to offer patients alternative and holistic treatments in addition to chemotherapy. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
Latest LFST
- Goldman initiated coverage on LifeStance Health Group with a new price target
- SEC Form 8-K filed by LifeStance Health Group Inc.
- Director Shuey Eric sold $1,951,763 worth of shares (243,362 units at $8.02) (SEC Form 4)
- Director Black Darren M. sold $47,315,281 worth of shares (5,899,661 units at $8.02) (SEC Form 4)
- Director Bessler Robert sold $4,611,773 worth of shares (575,034 units at $8.02) (SEC Form 4)
- Large owner Tpg Gp A, Llc sold $226,821,183 worth of shares (28,281,943 units at $8.02) (SEC Form 4)
- SEC Form 8-K filed by LifeStance Health Group Inc.
- Director Bessler Robert sold $641,250 worth of shares (75,000 units at $8.55) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by LifeStance Health Group Inc.
- SEC Form 424B7 filed by LifeStance Health Group Inc.
Latest TOI
- Large owner Chernett Jorey bought $57,000 worth of shares (12,000 units at $4.75), increasing direct ownership by 0.11% to 10,579,858 units (SEC Form 4)
- The Oncology Institute Chief Medical Officer to Speak on Value-Based Specialty Care at APG Spring Conference
- Chief Medical Officer Podnos Yale disposed of $8,068 worth of shares (1,805 units at $4.47), decreasing direct ownership by 0.63% to 282,978 units (SEC Form 4)
- Chief Executive Officer Virnich Daniel disposed of $103,069 worth of shares (23,058 units at $4.47), decreasing direct ownership by 0.98% to 2,337,166 units (SEC Form 4)
- Chief Financial Officer Carter Robert Ross disposed of $7,170 worth of shares (1,604 units at $4.47), decreasing direct ownership by 0.39% to 414,801 units (SEC Form 4)
- The Oncology Institute Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Large owner Chernett Jorey bought $156,595 worth of shares (38,500 units at $4.07), increasing direct ownership by 0.37% to 10,567,858 units (SEC Form 4)
- Large owner Chernett Jorey bought $122,700 worth of shares (30,000 units at $4.09), increasing direct ownership by 0.29% to 10,529,358 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13D/A filed by The Oncology Institute Inc.
- The Oncology Institute to Participate in B. Riley Securities Institutional Investor Conference